SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-030105
Filing Date
2017-05-05
Accepted
2017-05-05 10:54:38
Documents
4
Period of Report
2017-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-12419_18k.htm 8-K 26550
2 EX-99.1 a17-12419_1ex99d1.htm EX-99.1 109850
3 EX-99.2 a17-12419_1ex99d2.htm EX-99.2 36058
4 GRAPHIC g124191mmi001.jpg GRAPHIC 2724
  Complete submission text file 0001104659-17-030105.txt   177455
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 17816727
SIC: 3841 Surgical & Medical Instruments & Apparatus